(ORTERONEL (TAK-700) is a compound that has entered Phase III clinical trials for the treatment of castration-resistant prostate cancer.)
Basic informationMore
- Product Name:ORTERONEL (TAK-700) is a compound that has entered Phase III clinical trials for the treatment of castration-resistant prostate cancer.
- Synonyms: ORTERONEL (TAK-700) is a compound that has entered Phase III clinical trials for the treatment of castration-resistant prostate cancer.
- CAS:
- MF:
- MW:0
- EINECS:
- Mol File:Mol File
-
Browse by Nationality Suppliers >China suppliers
Recommend You Select Member Companies